DDX3X,,

Arpit Sharma1, Shruti S Raut1, Alok Shukla1

  • 1Biomolecular Engineering Laboratory, School of Biochemical Engineering, Indian Institute of Technology (BHU), Varanasi, 221005, India.

概括

由于抗药性,质母细胞瘤的治疗面临着挑战. 这篇评论探讨了质母细胞瘤的遗传学,Temozolomide耐药性,DDX3X蛋白质的作用和自,突出了黄素等潜在的治疗策略.